Replies to post #101131 on Biotech Values

[mouton29]

Bill Marth on Lovenox and Copaxone:

"[Copaxone] is much, much different—vastly more complex—than Lovenox will ever be."

Does this mean that the complexity of Lovenox is changing, increasing day by day?